Clin Case Rep Int | Volume 4, Issue 1 | Case Report | Open Access

Colchicine May not be Preventive in COVID-19 Pneumonia: Case Report

Hasan Kayabasi*, Mustafa Behcet Demirbas, Ezgi Ersoy Yesil and Dede Sit

Department of Nephrology, Health Sciences University, Turkey

*Correspondance to: Hasan Kayabasi 

Fulltext PDF


The recent outbreak of Coronavirus Disease 2019 (COVID-19) continues to evolve in many countries and pose life-threatening clinical issues to global public health. There is no vaccine or therapeutic proven options to prevent COVID-19 infection. It has been speculated that some immunomodulating drugs may have an effect on the progression of this infection. It is reasonable that colchicine may be tested in the context of COVID-19 to detect its immunomodulatory effects which may prevent acute respiratory distress syndrome. We discussed a case with COVID-19 pneumonia using colchicine successfully treated and reviewed the literature.




Kayabasi H, Demirbas MB, Yesil EE, Sit D. Colchicine May not be Preventive in COVID-19 Pneumonia: Case Report. Clin Case Rep Int. 2020; 4: 1167.

Subscribe to Our Newsletter